Print Print    Close Close

2 Nobel judges to be dismissed over stem-cell doctor scandal

Published September 06, 2016

Associated Press
3a9983f6-

Researchers have figured out a way to print 3D blocks of living stem cells. (Wei Sun/Drexel University)

The panel that awards the Nobel Prize in medicine is dismissing two judges for their roles in a scandal over a disgraced stem cell scientist at Stockholm's Karolinska Institute.

Nobel Assembly secretary Thomas Perlmann told Swedish news agency TT on Tuesday that Harriet Wallberg and Anders Hamsten would be asked to leave the 50-member group, which will announce the annual award next month.

Wallberg and Hamsten have already left high-ranking jobs at Karolinska amid scathing criticism of how the institute handled allegations of scientific misconduct against stem-cell scientist Dr. Paolo Macchiarini.

More on this...

  • Israeli firms develop high-speed 3-D printer for stem cells
  • Researchers testing stem cells to treat Alzheimer’s in first-of-its-kind trial
  • Scientists develop new human stem cells with half a genome

Once considered a pioneer in windpipe transplants, Macchiarini was fired after being accused of falsifying his resume and misrepresenting his work.

Prosecutors are investigating him for involuntary manslaughter in connection with two patients who died. He disputes all charges.

Print Print    Close Close

URL

https://www.foxnews.com/health/2-nobel-judges-to-be-dismissed-over-stem-cell-doctor-scandal

  • Home
  • Video
  • Politics
  • U.S.
  • Opinion
  • Entertainment
  • Tech
  • Science
  • Health
  • Travel
  • Lifestyle
  • World
  • Sports
  • Weather
  • Privacy
  • Terms

This material may not be published, broadcast, rewritten, or redistributed. © FOX News Network, LLC. All rights reserved. Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. Mutual Fund and ETF data provided by LSEG. Do Not Sell my Personal Information - New Terms of Use - FAQ